Santen Pharmaceutical Co Ltd - Company Profile

Powered by

All the sales intelligence you need on Santen Pharmaceutical Co Ltd in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Santen Pharmaceutical Co Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Santen Pharmaceutical Co Ltd.

Back to companies

Santen Pharmaceutical Co Ltd: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Santen Pharmaceutical Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Santen Pharmaceutical Co Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Takeshi Ito

President; Director; Chief Executive Officer Executive Board Since: 2022 Age: 66

Mr. Takeshi Ito has been the President, Director, and Chief Executive Officer of the company since 2022. Prior to this, he served as the Executive Vice President and Head of Japan Sales and Marketing Division, and Head of Japan Business of the company. Previously, he served as the Managing Executive Officer and General Manager of Pharmaceutical Business Division of the company. Mr. Takeshi also served as the General Manager of the Surgical Division of the company.

Read Hide full bio of Takeshi Ito

Rie Nakajima

Chief Operating Officer; Director; Executive Officer Executive Board Since: 2023 Age: 48

Ms. Rie Nakajima has been the Executive Officer, Chief Operating Officer, and Director of the company since 2023. Prior to this, she served as the Vice President, Strategy and Innovation Lead at Organon from 2021 to 2023. Previously, she served as the Vice President of Organon Strategy and Innovation Lead at Merck & Co Inc.

Read Hide full bio of Rie Nakajima

Kazuo Koshiji

Chief Financial Officer Senior Management Since: 2012

Mr. Kazuo Koshiji has been the Chief Financial Officer of the company since 2012. Prior to this, he served as the Chief Researcher/Consultant of MUFG Research & Consulting from 1997 to 2005; and led the business-development sections at Sumitomo Rubber Industries and Itoman Corporation.

Read Hide full bio of Kazuo Koshiji

Daisuke Nakata

Chief Digital Officer; Chief Information Officer Senior Management Since: 2025

Mr. Daisuke Nakata has been the Chief Information Officer and Chief Digital Officer of the company since 2025. Prior to this, he served as the Head of IT Strategy and Planning at Ono Pharmaceutical Co Ltd.

Read Hide full bio of Daisuke Nakata

Mika Masunari

General Counsel; Chief Risk Officer; Chief Compliance Officer Senior Management Since: 2025

Ms. Mika Masunari has been the General Counsel, Chief Risk Officer, and Chief Compliance Officer of the company since October 2025. Prior to this, she served as the Legal Director of the Business Development Department from 2016; and Vice President, and Head of Legal and Compliance at Santen Inc since 2017.

Read Hide full bio of Mika Masunari
Gain a 360-degree view of Santen Pharmaceutical Co Ltd and make more informed decisions for your business Gain a 360-degree view of Santen Pharmaceutical Co Ltd and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer